Atlas Trials

Topical Double-blind, Randomized, Placebo-controlled Study in Psoriasis Patients

Clinical trial NCT01936337 · COMPLETED

Trial details

NCT number
NCT01936337
Sponsor
Delenex Therapeutics AG
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Psoriasis Vulgaris
Start date
2013-08-01
Primary completion
2014-06-01
Enrollment
59

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.